Home » Topics » BioWorld

BioWorld
RSS

BEARISH REACTION TO CETUS-CHIRON DEAL

July 23, 1991

RIBI AMENDS PACT WITH D. BLECH

July 22, 1991

APPOINTMENTS AND ADVANCEMENTS

July 22, 1991

INTERNEURON GETS RIGHTS FOR MELATONIN

July 22, 1991

OLIGONUCLEOTIDES INHIBIT HIV EXPRESSION

July 22, 1991

FDA PANEL GRANTS ddI QUALIFIED APPROVAL

July 22, 1991

SYNERGEN OFFERS TO BUY PARTNER

July 19, 1991

AMGEN REPORTS $48.4 MILLION LOSS

July 19, 1991

G-CSF REDUCES CHEMO SIDE EFFECT

July 19, 1991

CYTRX GETS MILESTONE PAYMENT FOR RHEOTHRX

July 19, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...